Novitium Pharma Issues Voluntary National Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)

[ad_1]

Voluntarily recalling all portions and much, inside expiry, of Ranitidine Hydrochloride Capsules within the US to the buyer stage. Ranitidine Hydrochloride Capsules are being recalled due to potential N-Nitrosodimethylamine (NDMA) quantities above ranges established by the FDA.

[ad_2]

Source link